The investment objective is to provide capital growth from a diverse range of asset classes, for example equities, fixed income, property related investments and cash mainly in the United Kingdom.
Name | % Net Assets |
---|---|
Treasury 4.75% 2020 | 6.0% |
Treasury 5% 2012 | 3.9% |
BG Group | 2.8% |
Novartis | 1.8% |
Spirax-Sarco Engineering | 1.7% |
HSBC Infrastructure | 1.6% |
WPP | 1.6% |
Covidien | 1.6% |
Johnson Matthey | 1.5% |
SABMiller | 1.5% |
Key | % Net Assets |
---|---|
Treasury 4.75% 2020 | 6.0% |
Treasury 5% 2012 | 3.9% |
BG Group | 2.8% |
Novartis | 1.8% |
Other | 85.5% |
Date | 21-Nov-2024 |
---|---|
NAV | 262.50p |
Currency | GBP |
Change | 0.60p |
% | 0.23% |
YTD change | 12.00p |
YTD % | 4.79% |
Fund Inception | 24/07/2009 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £500 |
Savings | £50 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research